These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 35288462)

  • 1. ZEB1 transcription factor promotes immune escape in melanoma.
    Plaschka M; Benboubker V; Grimont M; Berthet J; Tonon L; Lopez J; Le-Bouar M; Balme B; Tondeur G; de la Fouchardière A; Larue L; Puisieux A; Grinberg-Bleyer Y; Bendriss-Vermare N; Dubois B; Caux C; Dalle S; Caramel J
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma.
    Martins Nascentes Melo L; Herrera-Rios D; Hinze D; Löffek S; Oezel I; Turiello R; Klein J; Leonardelli S; Westedt IV; Al-Matary Y; Egea-Rodriguez S; Brenzel A; Bau M; Sucker A; Hadaschik E; Wirsdörfer F; Hanenberg H; Uhlenbrock N; Rauh D; Poźniak J; Rambow F; Marine JC; Effern M; Glodde N; Schadendorf D; Jablonska J; Hölzel M; Helfrich I
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37028818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB1-mediated fibroblast polarization controls inflammation and sensitivity to immunotherapy in colorectal cancer.
    Menche C; Schuhwerk H; Armstark I; Gupta P; Fuchs K; van Roey R; Mosa MH; Hartebrodt A; Hajjaj Y; Clavel Ezquerra A; Selvaraju MK; Geppert CI; Bärthel S; Saur D; Greten FR; Brabletz S; Blumenthal DB; Weigert A; Brabletz T; Farin HF; Stemmler MP
    EMBO Rep; 2024 Aug; 25(8):3406-3431. PubMed ID: 38937629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint.
    Zhao L; Liu Y; Zhang J; Liu Y; Qi Q
    Cell Death Dis; 2019 Sep; 10(10):731. PubMed ID: 31570691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
    Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
    Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 8. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
    Chen X; Wang K; Jiang S; Sun H; Che X; Zhang M; He J; Wen Y; Liao M; Li X; Zhou X; Song J; Ren X; Yi W; Yang J; Chen X; Yin M; Cheng Y
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35347072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
    Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
    Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression.
    Chen Y; Lu X; Montoya-Durango DE; Liu YH; Dean KC; Darling DS; Kaplan HJ; Dean DC; Gao L; Liu Y
    Sci Rep; 2017 Mar; 7(1):45. PubMed ID: 28246385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
    Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.
    Wels C; Joshi S; Koefinger P; Bergler H; Schaider H
    J Invest Dermatol; 2011 Sep; 131(9):1877-85. PubMed ID: 21593765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1: Catalyst of immune escape during tumor metastasis.
    Lu J; Fei F; Wu C; Mei J; Xu J; Lu P
    Biomed Pharmacother; 2022 Sep; 153():113490. PubMed ID: 36076506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer.
    Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M
    Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response.
    Tanagala KKK; Morin-Baxter J; Carvajal R; Cheema M; Dubey S; Nakagawa H; Yoon A; Cheng YL; Taylor A; Nickerson J; Mintz A; Momen-Heravi F
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
    Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
    Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.
    Giammona A; De Vellis C; Crivaro E; Maresca L; Amoriello R; Ricci F; Anichini G; Pietrobono S; Pease DR; Fernandez-Zapico ME; Ballerini C; Stecca B
    J Exp Clin Cancer Res; 2024 Aug; 43(1):214. PubMed ID: 39090759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
    Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
    Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.